Product Information
Name:MJN228
Brand:Biosynth
Description:MJN228 is an experimental drug that binds to a specific site on the protein. It is being developed as a potential treatment for obesity, diabetes, and other metabolic diseases. MJN228 has been shown to bind to lipids, which are fatty molecules that are important in metabolism. Binding of MJN228 to these lipids may alter the way they interact with proteins.
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:364.4 g/mol
Formula:C20H20N4O3
Purity:Min. 95%
Technical inquiry about: MJN228
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.